5-(Carboethoxymethylidene)hydantoin-13C,15N2 is an intermediate formed in the synthesis of Orotic Acid-13C,15N2 Monohydrate, a labeled orotic acid, used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.
Molecular Weight:
187.13
Form:
Supplied as a Colorless crystals
* VAT and and shipping costs not included. Errors and price changes excepted
